Oscillators indicate a decent risk/reward entry now on ATHX
(with tight stop). No chart reversal pattern apparent yet. High call interest and several pipeline catalysts set the stage early into next year. As a Plus ++ expect heighten interest in small tech bio regen medicine stocks as a new bio sector ETF
during January kicks-off with PRMF's IPO
I'd expect this IPO
to have a positive affect on many of the regeneration medicine tickers.